Sponsors (7)
The bill shifts the patent system toward stronger, more court-centered protection for patent owners—boosting incentives and funding stability for inventors and the USPTO—at the cost of reduced administrative challenges, higher litigation risk and costs, less transparency, and potential higher prices and complexity for consumers, competitors, and international filers.
Patent owners (including small inventors and small businesses) gain stronger property protection and greater access to Article III courts to resolve validity, reducing the risk that issued patents are undone administratively.
Patent holders can more readily obtain and enforce injunctions after a finding of infringement, improving their ability to protect market exclusivity and potentially increasing returns on R&D.
The bill restores pre‑AIA rules (including a U.S. one‑year grace period and first‑to‑invent elements), giving individual inventors and small teams more leeway to disclose, seek investment, and commercialize before losing U.S. patent rights.
Competitors, consumers, and the public face higher risk that weak or overly broad patents remain in force because the bill removes or limits administrative patent‑challenge procedures (IPR/PGR/ex parte constraints) and shifts validity contests into costlier courts.
Accused infringers and challengers will likely encounter higher litigation costs and a tougher path to invalidate patents (stronger presumptions of validity, tolling of term, and injunction presumptions), increasing legal risk and expense for competitors and startups.
Patients and consumers may pay higher prices or face restricted access to diagnostics, treatments, and downstream products because longer/stronger exclusivity and expanded patent eligibility (e.g., diagnostics, software) can delay competition and generics.
Based on analysis of 24 sections of legislative text.
Overhauls patent law: ends automatic publication, restores pre‑AIA first‑to‑invent and grace period, abolishes PTAB proceedings, broadens eligibility, strengthens validity and injunction presumptions, and creates a USPTO fee fund.
Official title: To promote the leadership of the United States in global innovation by establishing a robust patent system that restores and protects the right of inventors to own and enforce private property rights in inventions and discoveries, and for other purposes.
Introduced October 24, 2025 by Thomas Massie · Last progress October 24, 2025
Rewrites major parts of U.S. patent law to strengthen patent holders’ rights and reduce administrative patent challenges. It would end automatic 18‑month publication of applications (publication only on request or upon grant), restore pre‑America Invents Act (AIA) rules including first‑to‑invent and the old one‑year grace period, abolish the PTAB’s post‑grant adversarial proceedings (IPR/PGR) and reinstate pre‑AIA adjudicatory structures, broaden patent eligibility, create a permanent USPTO fee revolving fund, and add strong statutory presumptions favoring patent validity and injunctive relief. The bill treats patents more explicitly as private property revocable only by courts and shifts many patent disputes back toward district courts and away from administrative proceedings.